KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gevo (GEVO) Accounts Payables (2016 - 2025)

Gevo (GEVO) has disclosed Accounts Payables for 16 consecutive years, with $36.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 6673.28% to $36.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.5 million, a 6673.28% increase, with the full-year FY2025 number at $36.5 million, up 6673.28% from a year prior.
  • Accounts Payables was $36.5 million for Q4 2025 at Gevo, down from $40.0 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $43.4 million in Q2 2025 to a low of $100000.0 in Q1 2023.
  • A 5-year average of $20.1 million and a median of $22.4 million in 2024 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: plummeted 99.25% in 2023, then skyrocketed 21456.0% in 2024.
  • Gevo's Accounts Payables stood at $28.2 million in 2021, then dropped by 12.04% to $24.8 million in 2022, then tumbled by 89.02% to $2.7 million in 2023, then crashed by 80.17% to $539000.0 in 2024, then surged by 6673.28% to $36.5 million in 2025.
  • Per Business Quant, the three most recent readings for GEVO's Accounts Payables are $36.5 million (Q4 2025), $40.0 million (Q3 2025), and $43.4 million (Q2 2025).